1887

Abstract

Simian herpes B virus (SHBV) is the herpes simplex virus (HSV) homologue for the species . Unlike in its natural host, and unlike other animal herpesviruses, SHBV causes high mortality in accidentally infected humans. SHBV-infected cells, like those infected with HSV-1 and equine herpesvirus types 1 and 4, express complement C3 receptor activity. To study immunoregulatory functions involved in susceptibility/resistance against interspecies transmission, the SHBV glycoprotein C (gC) gene (encoding 467 aa) was isolated. Sequence analysis revealed amino acid identity with gC proteins from HSV-2 (46·9 %), HSV-1 (44·5 %) and pseudorabies virus (21·2 %). Highly conserved cysteine residues were also noted. Similar to gC, gC is less glycosylated than gC, resulting in a molecular mass of 65 kDa if expressed in replication-deficient vaccinia virus Ankara. Stable transfectants expressing full-length gC on the cell surface induced C3 receptor activity and were substantially protected from complement-mediated lysis; no protection was observed with control constructs. This suggests that expression of the gC homologues on infected cell surfaces might also contribute to the survival of infected cells in addition to decreased virion inactivation. Interestingly, soluble gC isolated from protein-free culture supernatants did not interfere with the binding of the alternative complement pathway activator properdin to C3b, which is similar to our findings with gC and could be attributed to major differences in the amino-terminal portion of the protein with extended deletions in both gC and gC. Binding of recombinant gC to polysulphates was observed. This, together with the heparin-sensitivity of the gC–C3 interaction on the infected cell surface, suggests a role in adherence to heparan sulphate, similar to the gC proteins of other herpesviruses.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.18949-0
2003-05-01
2019-10-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/84/5/vir841091.html?itemId=/content/journal/jgv/10.1099/vir.0.18949-0&mimeType=html&fmt=ahah

References

  1. Cole, J. L., Housley, G. A., Jr, Dykman, T. R., MacDermott, R. P. & Atkinson, J. P. ( 1985; ). Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A 82, 859–863.[CrossRef]
    [Google Scholar]
  2. Cooper, N. R. ( 1991; ). Complement evasion strategies of microorganisms. Immunol Today 12, 327–331.[CrossRef]
    [Google Scholar]
  3. Davenport, D. S., Johnson, D. R., Holmes, G. P., Jewett, D. A., Ross, S. C. & Hilliard, J. K. ( 1994; ). Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan. Clin Infect Dis 19, 33–41.[CrossRef]
    [Google Scholar]
  4. Edens, R. E., Linhardt, R. J. & Weiler, J. M. ( 1993; ). Heparin is not just an anticoagulant anymore: six and one-half decades of studies on the ability of heparin to regulate complement activity. In Complement Today (Complement Profiles), pp. 96–120. Edited by J. M. Cruse & R. E. Lewis, Jr. Basel: Karger.
  5. Engels, M., Palatini, M., Metzler, A. E., Probst, U., Kihm, U. & Ackermann, M. ( 1992; ). Interactions of bovine and caprine herpesviruses with the natural and the foreign hosts. Vet Microbiol 33, 69–78.[CrossRef]
    [Google Scholar]
  6. Falke, D. ( 1961; ). Isolation of two variants with different cytopathic properties from a strain of herpes B virus. Virology 14, 492–495.[CrossRef]
    [Google Scholar]
  7. Falke, D. ( 1964; ). Serologic relationship between B virus and herpes simplex virus using complement fixation assay. Z Hyg 150, 185–193 (in German).[CrossRef]
    [Google Scholar]
  8. Fries, L. F., Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Hammer, C. H. & Frank, M. M. ( 1986; ). Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137, 1636–1641.
    [Google Scholar]
  9. Gerber, S. I., Belval, B. J. & Herold, B. C. ( 1995; ). Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214, 29–39.[CrossRef]
    [Google Scholar]
  10. Griffiths, A., Renfrey, S. & Minson, T. ( 1998; ). Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non-polarized cells. J Gen Virol 79, 807–812.
    [Google Scholar]
  11. Harrington, L., Wall, L. V. & Kelly, D. C. ( 1992; ). Molecular cloning and physical mapping of the genome of simian herpes B virus and comparison of genome organization with that of herpes simplex virus. J Gen Virol 73, 1217–1226.[CrossRef]
    [Google Scholar]
  12. Hidaka, Y., Sakuma, S., Kumano, Y., Minagawa, H. & Mori, R. ( 1990; ). Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis. Arch Virol 113, 195–207.
    [Google Scholar]
  13. Hidaka, Y., Sakai, Y., Toh, Y. & Mori, R. ( 1991; ). Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J Gen Virol 72, 915–921.[CrossRef]
    [Google Scholar]
  14. Hilliard, J. K., Black, D. & Eberle, R. ( 1989; ). Simian alphaherpesviruses and their relation to the human herpes simplex virus. Arch Virol 109, 83–102.[CrossRef]
    [Google Scholar]
  15. Horstmann, R. D., Pangburn, M. K. & Müller-Eberhard, H. J. ( 1985; ). Species specificity of recognition by the alternative pathway of complement. J Immunol 134, 1101–1104.
    [Google Scholar]
  16. Huemer, H. P., Bröker, M., Larcher, C., Lambris, J. D. & Dierich, M. P. ( 1989; ). The central segment of herpes simplex virus type 1 glycoprotein C (gC) is not involved in C3b binding: demonstration by using monoclonal antibodies and recombinant gC expressed in Escherichia coli. J Gen Virol 70, 1571–1578.[CrossRef]
    [Google Scholar]
  17. Huemer, H. P., Larcher, C., Dierich, M. P. & Falke, D. ( 1992a; ). Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement. Arch Virol 127, 291–303.[CrossRef]
    [Google Scholar]
  18. Huemer, H. P., Larcher, C. & Coe, N. E. ( 1992b; ). Pseudorabies glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23, 271–280.[CrossRef]
    [Google Scholar]
  19. Huemer, H. P., Larcher, C., Van Drunen Littel-van den Hurk, S. & Babiuk, L. A. ( 1993a; ). Species selective interaction of Alphaherpesvirinae with the ‘unspecific’ immune system of the host. Arch Virol 130, 353–364.[CrossRef]
    [Google Scholar]
  20. Huemer, H. P., Wang, Y., Garred, P., Koistinen, V. & Oppermann, S. ( 1993b; ). Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 79, 639–647.
    [Google Scholar]
  21. Huemer, H. P., Nowotny, N., Crabb, B. S., Meyer, H. & Hübert, P. H. ( 1995; ). gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37, 113–126.[CrossRef]
    [Google Scholar]
  22. Huemer, H. P., Strobl, B., Shida, H. & Czerny, C. P. ( 2000a; ). Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal. J Virol Methods 85, 1–10.[CrossRef]
    [Google Scholar]
  23. Huemer, H. P., Strobl, B. & Nowotny, N. ( 2000b; ). Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme. Vaccine 18, 1320–1326.[CrossRef]
    [Google Scholar]
  24. Huemer, H. P., Larcher, C., Czedik-Eysenberg, T., Nowotny, N. & Reifinger, M. ( 2002; ). Fatal infection of a pet monkey with human herpesvirus. Emerg Infect Dis 8, 639–642.[CrossRef]
    [Google Scholar]
  25. Ikeda, K., Wakimoto, H., Ichikawa, T., Jhung, S., Hochberg, F. H., Louis, D. N. & Chiocca, E. A. ( 2000; ). Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol 74, 4765–4775.[CrossRef]
    [Google Scholar]
  26. Isaacs, S. N., Kotwal, J. & Moss, B. ( 1992; ). Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89, 628–632.[CrossRef]
    [Google Scholar]
  27. Laquerre, S., Argnani, R., Anderson, D. B., Zucchini, S., Manservigi, R. & Glorioso, J. C. ( 1998; ). Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 72, 6119–6130.
    [Google Scholar]
  28. Liang, X., Babiuk, L. A. & Zamb, T. J. ( 1992; ). An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 189, 629–639.[CrossRef]
    [Google Scholar]
  29. Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y. & Otsuka, H. ( 2002; ). Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). Virus Res 84, 79–87.[CrossRef]
    [Google Scholar]
  30. McNearney, T. A., Odell, C., Holers, V. M., Spear, P. G. & Atkinson, J. P. ( 1987; ). Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med 166, 1525–1535.[CrossRef]
    [Google Scholar]
  31. Medof, M. E., Kinoshita, T. & Nussenzweig, V. ( 1984; ). Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 160, 1558–1578.[CrossRef]
    [Google Scholar]
  32. Mettenleiter, T. C., Schreurs, C., Zuckermann, F., Ben-Porat, T. & Kaplan, A. S. ( 1988; ). Role of glycoprotein gIII of pseudorabies virus in virulence. J Virol 62, 2712–2717.
    [Google Scholar]
  33. Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H. & Arvin, A. M. ( 1998; ). Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72, 965–974.
    [Google Scholar]
  34. Norcott, J. P. & Brown, D. W. G. ( 1993; ). Competitive radioimmunoassay to detect antibodies to herpes B virus and SA8 virus. J Clin Microbiol 31, 931–935.
    [Google Scholar]
  35. Ohmann, H. B. & Babiuk, L. A. ( 1988; ). Induction of receptors for complement and immunoglobulins by herpesviruses of various species. Virus Res 9, 335–342.[CrossRef]
    [Google Scholar]
  36. Rother, R. P., Rollins, S. A., Fodor, W. L., Albrecht, J. C., Setter, E., Fleckenstein, B. & Squinto, S. P. ( 1994; ). Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68, 730–737.
    [Google Scholar]
  37. Sawitzky, D., Hampl, H. & Habermehl, K. O. ( 1990; ). Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins. J Gen Virol 71, 1221–1225.[CrossRef]
    [Google Scholar]
  38. Scheiflinger, F., Falkner, F. G. & Dorner, F. ( 1996; ). Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain. Arch Virol 141, 663–669.[CrossRef]
    [Google Scholar]
  39. Skinner, G. R. B., Ahmad, A. & Davies, J. A. ( 2001; ). The infrequency of transmission of herpesviruses between humans and animals: postulation of an unrecognised protective host mechanism. Comp Immunol Microbiol Infect Dis 24, 255–269.[CrossRef]
    [Google Scholar]
  40. Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H. & Saifuddin, M. ( 1995; ). Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 155, 4376–4381.
    [Google Scholar]
  41. Yu, J., Dong, S., Rushmere, N. K., Morgan, B. P., Abagyan, R. & Tomlinson, S. ( 1997; ). Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity. Biochemistry 36, 9423–9428.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.18949-0
Loading
/content/journal/jgv/10.1099/vir.0.18949-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error